Literature DB >> 23252409

Antipsychotic use in nursing home residents admitted with hip fracture.

Hye-Young Jung1, Marissa Meucci, Mark Aaron Unruh, Vincent Mor, David Dosa.   

Abstract

OBJECTIVES: To evaluate the association between receiving antipsychotics and the outcomes of a cohort of nursing home (NH) residents with and without presumed delirium after hip fracture.
DESIGN: Population-based cohort study.
SETTING: Eleven thousand one hundred nineteen nursing homes nationwide from January 1, 2000, to December 31, 2007. PARTICIPANTS: First-time NH admissions with hip fracture (n = 77,759). MEASUREMENTS: The Nursing Home Confusion Assessment Method was used to identify residents with no delirium, subsyndromal delirium, and full delirium. Propensity score reweighting was used, with analyses stratified according to delirium level.
RESULTS: In subjects with no delirium symptoms, approximately 5% (n = 3,250) received antipsychotic drugs. These individuals were less likely to be discharged home (odds ratio (OR) = 0.68, P < .001), had a higher likelihood of death before nursing home discharge (OR = 1.28, P = .03), stayed in nursing homes longer (β 2.83, P = .05), and had less functional improvement at discharge (β -0.47, P = .03). Receipt of antipsychotics in participants with mild delirium was associated with a lower likelihood of discharge home (OR = 0.74, P = .03).
CONCLUSION: In NH residents with hip fracture and no delirium symptoms, use of antipsychotics was associated with worse outcomes, with the exception of rehospitalization. No clear benefits were associated with antipsychotic use for those with presumed delirium.
© 2012, Copyright the Authors Journal compilation © 2012, The American Geriatrics Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23252409      PMCID: PMC3854869          DOI: 10.1111/jgs.12043

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  26 in total

1.  Scaling ADLs within the MDS.

Authors:  J N Morris; B E Fries; S A Morris
Journal:  J Gerontol A Biol Sci Med Sci       Date:  1999-11       Impact factor: 6.053

2.  Influence of facility characteristics on use of antipsychotic medications in nursing homes.

Authors:  C M Hughes; K L Lapane; V Mor
Journal:  Med Care       Date:  2000-12       Impact factor: 2.983

Review 3.  Treatment with atypical antipsychotics: new indications and new populations.

Authors:  I D Glick; S R Murray; P Vasudevan; S R Marder; R J Hu
Journal:  J Psychiatr Res       Date:  2001 May-Jun       Impact factor: 4.791

4.  Effect of a pharmacist-led multicomponent intervention focusing on the medication monitoring phase to prevent potential adverse drug events in nursing homes.

Authors:  Kate L Lapane; Carmel M Hughes; Lori A Daiello; Kathleen A Cameron; Janice Feinberg
Journal:  J Am Geriatr Soc       Date:  2011-06-07       Impact factor: 5.562

5.  Antipsychotic use and the risk of diabetes in nursing home residents with dementia.

Authors:  Jessica J Jalbert; Lori A Daiello; Charles B Eaton; Susan C Miller; Kate L Lapane
Journal:  Am J Geriatr Pharmacother       Date:  2011-05-19

6.  Acute confusional state in the elderly following hip surgery: incidence, risk factors and complications.

Authors:  P Galanakis; H Bickel; R Gradinger; S Von Gumppenberg; H Förstl
Journal:  Int J Geriatr Psychiatry       Date:  2001-04       Impact factor: 3.485

7.  Maintaining continuity of care for nursing home residents: effect of states' Medicaid bed-hold policies and reimbursement rates.

Authors:  Orna Intrator; Mark Schleinitz; David C Grabowski; Jacqueline Zinn; Vincent Mor
Journal:  Health Serv Res       Date:  2008-09-08       Impact factor: 3.402

8.  Unexplained variation across US nursing homes in antipsychotic prescribing rates.

Authors:  Yong Chen; Becky A Briesacher; Terry S Field; Jennifer Tjia; Denys T Lau; Jerry H Gurwitz
Journal:  Arch Intern Med       Date:  2010-01-11

9.  Temporal and Geographic variation in the validity and internal consistency of the Nursing Home Resident Assessment Minimum Data Set 2.0.

Authors:  Vincent Mor; Orna Intrator; Mark Aaron Unruh; Shubing Cai
Journal:  BMC Health Serv Res       Date:  2011-04-15       Impact factor: 2.655

10.  Differential risk of death in older residents in nursing homes prescribed specific antipsychotic drugs: population based cohort study.

Authors:  K F Huybrechts; T Gerhard; S Crystal; M Olfson; J Avorn; R Levin; J A Lucas; S Schneeweiss
Journal:  BMJ       Date:  2012-02-23
View more
  6 in total

1.  Association of Clinical Outcomes With Surgical Repair of Hip Fracture vs Nonsurgical Management in Nursing Home Residents With Advanced Dementia.

Authors:  Sarah D Berry; Randi R Rothbaum; Douglas P Kiel; Yoojin Lee; Susan L Mitchell
Journal:  JAMA Intern Med       Date:  2018-06-01       Impact factor: 21.873

2.  Association of Private Equity Investment in US Nursing Homes With the Quality and Cost of Care for Long-Stay Residents.

Authors:  Robert Tyler Braun; Hye-Young Jung; Lawrence P Casalino; Zachary Myslinski; Mark Aaron Unruh
Journal:  JAMA Health Forum       Date:  2021-11-19

Review 3.  Medications and Prescribing Patterns as Factors Associated with Hospitalizations from Long-Term Care Facilities: A Systematic Review.

Authors:  Kate N Wang; J Simon Bell; Esa Y H Chen; Julia F M Gilmartin-Thomas; Jenni Ilomäki
Journal:  Drugs Aging       Date:  2018-05       Impact factor: 3.923

4.  Does More Therapy in Skilled Nursing Facilities Lead to Better Outcomes in Patients With Hip Fracture?

Authors:  Hye-Young Jung; Amal N Trivedi; David C Grabowski; Vincent Mor
Journal:  Phys Ther       Date:  2015-11-19

Review 5.  Scoping review of potential quality indicators for hip fracture patient care.

Authors:  Kristen B Pitzul; Sarah E P Munce; Laure Perrier; Lauren Beaupre; Suzanne N Morin; Rhona McGlasson; Susan B Jaglal
Journal:  BMJ Open       Date:  2017-03-21       Impact factor: 2.692

6.  A Review Exploring the Relationship Between Nursing Home Staffing and Antipsychotic Medication Use.

Authors:  T Joseph Mattingly
Journal:  Neurol Ther       Date:  2015-09-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.